Here's What Lifted Globus Medical (GMED) in Q4
Meridian Funds, managed by ArrowMark Partners, released its “Meridian Growth Fund” fourth-quarter 2025 investor letter. A copy of the same can be downloaded here. U.S.
Globus Medical Inc (GMED)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period: Filing is Ongoing
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Paradice Investment Management David Paradice | 528,055 | $46,104,482 | -21% | 8.98% |
| 2. | Bayforest Capital Theodoros Tsagaris | 2,076 | $181,256 | 0.14% | |
| 3. | Sivik Global Healthcare Krishen Sud | 40,000 | $3,492 | 1.01% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $53.88 | 615 | $33,136.20 | 2,005 | 2020-08-24 | Filing | |
| $47.75 | 690 | $32,947.50 | 1,390 | 2020-07-22 | Filing | |
| $48.20 | 700 | $33,740.00 | 700 | 2020-06-22 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $101.10 | 3,594 | $363,353.40 | 0 | 2026-01-08 | Filing | |
| $101.10 | 2,000 | $202,200.00 | 10,419 | 2026-01-08 | Filing | |
| $88.85 | 4,000 | $355,400.00 | 12,419 | 2025-12-12 | Filing | |
| $90.00 | 18,542 | $1,668,780.00 | 0 | 2025-12-01 | Filing | |
| $90.00 | 7,500 | $675,000.00 | 0 | 2025-11-25 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 10,549,455 | $921,072,916 | 0.01% | |
| 2. | 1,367,987 | $119,438,945 | 0.9% | |
| 3. | 447,174 | $39,038,290 | 0.06% | |
| 4. | 339,272 | $29,621,839 | 0% | |
| 5. | 319,591 | $27,903,490 | 0.15% |
News See All
Varied Growth Drivers Led Antipodes Global Value Strategy to Add Globus Medical (GMED) to Its Portfolio
Antipodes Partners recently published its “Antipodes Global Value Strategy” third-quarter 2025 investor letter, highlighting the key performance stocks, portfolio changes, and the market outlook.
Globus Medical, Inc. (NYSE:GMED) Q3 2025 Earnings Call Transcript
Operator: Welcome to Globus Medical's Third Quarter 2025 Earnings Call. [Operator Instructions] Please be advised that today's conference is being recorded.
Globus Medical (GMED) Sees Sequential Revenue Surge, Citizens JMP Maintains Market Perform Rating
Globus Medical Inc. (NYSE:GMED) ranks among the best mid-cap stocks with huge upside potential. Following the publication of Globus Medical Inc.
12 Best Mid-Cap Stocks with Huge Upside Potential
The Commerce Department said on August 29 that core inflation, which does not include food and energy expenses, stood at a 2.9% seasonally adjusted annual rate based on the personal consumption expenditures...
Globus Medical, Inc. (NYSE:GMED) Q2 2025 Earnings Call Transcript
Operator: Welcome to Globus Medical's Second Quarter 2025 Earnings Call. [Operator Instructions].
Canaccord Downgrades Globus Medical (GMED) PT to $90, Maintains Buy Rating
Globus Medical Inc. (NYSE:GMED) is one of the most undervalued stocks to buy and hold for 3 years.
Globus Medical Introduces DuraPro with Navigation to Enhance Surgical Workflows, Safety
Globus Medical Inc. (NYSE:GMED) is one of the best mid cap pharma stocks to buy. On July 15, Globus Medical announced the introduction of DuraPro with Navigation.
10 Most Undervalued Stocks to Buy and Hold for 3 Years
On July 17, Lori Calvasina, RBC Capital Markets head of US equity strategy, joined 'Closing Bell' on CNBC to discuss whether the market is fully valued at present levels.
Hedge Fund Resource Center Billionaire Hedge Funds
